Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ClinicalTrials.gov Is "Right Place" To List Initiated Trials, NIH Agrees

This article was originally published in The Pink Sheet Daily

Executive Summary

The National Library of Medicine's database has the capacity to accept the trials and adequate software, NLM Director Lindberg says. Authentication or validation of certain international studies could pose a problem; FDA would be the "validator" for some of those trials.

You may also be interested in...



Senate Finance Considering Clinical Trials Registry Legislation

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is planning a bill to establish a clinical trial registry

Senate Finance Considering Clinical Trials Registry Legislation

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is planning a bill to establish a clinical trial registry

LillyTrials.com Unveils Five Ongoing Studies For Cymbalta

Phase IV Cymbalta studies include trial of patients who switched from other antidepressants. Lilly expects all eligible trials will be posted on the website within six months.

Related Content

Topics

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel